United Drug has announced that it intends to delist from the Irish Stock Exchange and seek inclusion on the FTSE UK index series.
The shares will cease trade on the ISEQ index on October 3 and subject to FTSE approval, would be included in the FTSE All-share index after the close of business on the 21 December 2012.
United Drug say the change will have no material effect on shareholder rights. Shareholders may opt to receive dividends in euro or sterling.
Liam FitzGerald, United Drug CEO, said that the change would increase the group's attractiveness to a wider international investor base but that United Drug would remain headquartered, incorporated and tax-resident in Ireland.
